Latest From Biotech Now

Get to Know GMOs Month Continues with the Science Behind GMOs

GMO Answers

During the month of October, GMO Answers encourages you to Get to Know GMOs. Ask your questions and join the conversation online. Each week we’re posting new information to help you get to know GMOs and better understand the role of biotechnology in agriculture. For week one we discussed the biggest misconceptions about GMOs and for week two we covered GMO basics. Moving into week three now, we’re demystifying the science of GMOs, showing how science is used to ensure the safety Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , ,

BIO Submits Joint Supplemental Comments on the USPTO March Guidance

Supreme Court

Last week BIO, alongside a number of member companies and private individuals, submitted supplemental comments to the U.S. Patent and Trademark Office concerning their March 2014 Guidance on patent subject matter eligibility. In July, BIO and international bio-industry associations had submitted comments to the USPTO expressing concern about the Guidance, and its impact on the patent eligibility of biotechnology inventions. Since July, USPTO staff has indicated a final revision to the Guidance would be released Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , , , , , ,

BIO Member Company Achieves Significant Milestone in Advanced Biofuel Technology


On Friday, October 17, 2014, Abengoa Bioenergy opened its 25-million gallon per year cellulosic ethanol biorefinery in Hugoton, Kansas.  Abengoa completed the construction of its facility in mid-August and began producing cellulosic ethanol at the end of September. The plant produces up to 25 million gallons a year using only raw biomass “second generation” for the production of ethanol, ie residues of agricultural crops and inedible stems and leaves that do not compete with grain for feed materials. Through Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Richard Pops: A Greater Patient Voice in Drug Development


In the October issue of MedNous, Alkermes’ CEO Richard Pops writes about the move toward increased engagement with patients in the development, review and delivery of new medicines, as well as the challenges and opportunities associated with access and reimbursement. Pops asserts that patients must organize to share data that can be used in regulatory decision-making. Furthermore, he writes that this input must be integrated through the process – from the early stages of development Read More >

Events, Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

As Midterm Elections Near Some Voters Will Have to Decide on More Than Who Will Control the State’s Legislature


As we close in on the “midterm” elections, not only will voters decide which parties will control the states’ legislatures but many will be asked to vote on contentious ballot initiatives. Colorado and Oregon each have statewide ballot initiatives pending that would force food companies to label any products derived from Genetically Modified Organisms (GMOs). In Maui County, Hawaii (including the islands of Maui, Molokai and Lanai) and in Humboldt County, California, voters will decide Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,